Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04620382Phase 1Completed
Phase 1, randomised, double-blind trial of midodrine in Neurogenic Orthostatic Hypotension (nOH) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Augmentation Index at 1 hour. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04620382.